CMS Approves Coverage for PQ Bypass TORUS 2 IDE Trial – Endovascular Today
December 19, 2019—PQ Bypass Inc. announced it has received approval for coverage from the Centers for Medicare and Medicaid Services (CMS) for t
Related Articles
Vascular Access Care in an Era of Increasingly Scarce Providers and Increasingly Complicated Patients – Endovascular Today
A case involving chronic venous occlusion in a patient with a recently constructed AV loop graft sheds light on the challenges with today’s dialysis access…
An Interview With Vivian L. Bishay, MD – Endovascular Today
Dr. Bishay discusses the keys to a successful interventional radiology program, her role as National Co-Principal Investigator of SYMPHONY-PE and the broader clinical trial landscape…
Acute Ischemic Stroke Due to Tandem Occlusion – Endovascular Today
Planning an endovascular approach for an uncommon scenario.
IVL for Dense, Complex Carotid Artery Disease – Endovascular Today
A case study on intravascular lithotripsy for the treatment of calcified carotid disease to demonstrate technical feasibility and the need for further study.
Decision-Making for Type II Endoleaks: Choosing an Approach and Embolic Agent – Endovascular Today
An overview of current strategies for managing type II endoleaks illustrated by a case of persistent endoleak and sac enlargement after fenestrated endovascular aneurysm repair.
Imperative Care’s SYMPHONY-PE IDE Study Completes Enrollment – Endovascular Today
May 13, 2025—Imperative Care, Inc announced the completion of patient enrollment in its SYMPHONY-PE study, which was conducted at 19 interventio
Terumo Neuro’s Sofia 88 Support Catheter Launched in United States – Endovascular Today
May 13, 2025—Terumo Neuro, a wholly owned subsidiary of Terumo Corporation, announced the commercial availability of the Sofia 88 neurovascular
Merit’s Wrapsody CIE Approved by Health Canada – Endovascular Today
May 13, 2025—Merit Medical Systems, Inc. announced recently that the company’s Wrapsody cell-impermeable endoprosthesis (CIE) received reg
Penumbra Commences STRIDE II Study of Lightning Bolt CAVT to Treat Lower Extremity ALI – Endovascular Today
May 7, 2025—Penumbra announced that it will begin recruitment for the STRIDE II study of its Lightning Bolt computer-assisted vacuum thrombectom